Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve 1) To consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek Ltd has informed BSE that its Board of Directors will meet on Friday, 13th February 2026. The main items on the agenda are to consider and approve the Un-Audited Financial Results (both Standalone and Consolidated) for the quarter ended 31st December 2025, along with the Limited Review Report for the same period. The trading window for insiders has been closed since 1st January 2026 and will remain closed until 48 hours after the results are made public. This is a standard regulatory intimation under SEBI LODR Regulations and does not contain any actual financial figures.
No immediate impact on shareholders or stock price — this is a routine pre-results announcement. Investors should watch for the actual Q3 FY26 numbers, which will be released after the Board meeting on 13th February 2026.